Review Article
Valuing the Economic Costs of Allergic Rhinitis, Acute Bronchitis, and Asthma from Exposure to Indoor Dampness and Mold in the US
Table 2
Number of AR patients attributable to dampness and mold and base case COI monetary value of impacts in 2014.
| | Number million | Monetary value million |
| AR patients | 3.59 | |
| Direct medical expenses (629.69/patient) | | 2,257.33 |
| Patient sick days | | | Working adults | 1.63 | 52.73 | Nonworking adults | 0.93 | 21.19 | Children | 0.45 | 5.13 | Total | 3.01 | 79.05 | Missed schooldays | 0.24 | |
| Patient reduced productivity (equivalent days) | | | Working adults | 4.59 | 148.68 | Nonworking adults | 2.63 | 59.75 | Children | 1.27 | 14.45 | Total | 8.49 | 222.88 | Missed schooldays | 0.68 | |
| Adult lost days for care for sick children | | | Working adults | 0.29 | 27.92 | Nonworking adults | 0.16 | 5.61 | Total | 0.45 | 33.53 |
| Total direct medical expenses | | 2,257.33 |
| Days & COI values for wage related losses | 11.95 | 335.46 |
| Total COI economic cost | | 2,592.79 |
|
|
Schooldays portion of school-age children days.
|